Palogic Value Management L.P. Has $1.93 Million Stock Position in Procter & Gamble Company (The) $PG

Palogic Value Management L.P. lifted its stake in Procter & Gamble Company (The) (NYSE:PG) by 5.1% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,126 shares of the company’s stock after acquiring an additional 586 shares during the quarter. Palogic Value Management L.P.’s holdings in Procter & Gamble were worth $1,932,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Nova Wealth Management Inc. acquired a new stake in shares of Procter & Gamble in the first quarter valued at about $26,000. Signature Resources Capital Management LLC grew its holdings in Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after purchasing an additional 72 shares during the period. Quarry LP bought a new position in Procter & Gamble during the first quarter worth about $33,000. Mid American Wealth Advisory Group Inc. bought a new position in Procter & Gamble during the second quarter worth about $34,000. Finally, RMG Wealth Management LLC bought a new position in Procter & Gamble during the second quarter worth about $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.7%

Shares of NYSE:PG opened at $150.70 on Friday. Procter & Gamble Company has a 12-month low of $146.96 and a 12-month high of $180.43. The stock has a market cap of $352.14 billion, a PE ratio of 22.00, a P/E/G ratio of 3.87 and a beta of 0.36. The business has a 50 day moving average of $153.89 and a 200-day moving average of $157.83. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company had revenue of $22.39 billion during the quarter, compared to analysts’ expectations of $22.23 billion. During the same quarter in the previous year, the company posted $1.93 earnings per share. The business’s revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s payout ratio is 61.75%.

Analyst Ratings Changes

PG has been the subject of a number of research analyst reports. UBS Group reduced their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Raymond James Financial reduced their price target on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a report on Monday, October 20th. BNP Paribas Exane reduced their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Morgan Stanley set a $175.00 price target on Procter & Gamble in a report on Monday, October 27th. Finally, BNP Paribas restated an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Twelve research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $171.53.

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 490 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the sale, the insider directly owned 12,616 shares in the company, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Andre Schulten sold 4,252 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares of the company’s stock, valued at approximately $8,219,202.16. This trade represents a 7.30% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 150,488 shares of company stock valued at $23,529,718 in the last quarter. Company insiders own 0.20% of the company’s stock.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.